Bruker (NASDAQ:BRKR) Reaches New 52-Week Low - Here's What Happened

Bruker Co. (NASDAQ:BRKR - Get Free Report)'s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as $45.08 and last traded at $45.30, with a volume of 1059827 shares changing hands. The stock had previously closed at $47.40.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Bank of America upped their price target on Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a report on Friday, December 13th. The Goldman Sachs Group raised Bruker from a "sell" rating to a "neutral" rating and set a $60.00 price target for the company in a report on Thursday, December 5th. Barclays cut their price target on Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Guggenheim reaffirmed a "buy" rating on shares of Bruker in a report on Monday, February 24th. Finally, Stifel Nicolaus cut their price target on Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a report on Friday, February 14th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $70.50.

Bruker Stock Performance

The firm has a market capitalization of $6.97 billion, a P/E ratio of 60.49, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. The stock has a 50-day moving average of $53.93 and a 200 day moving average of $58.57. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60.

Remove Ads

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. On average, research analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.44%. The ex-dividend date is Monday, March 17th. Bruker's dividend payout ratio is 26.32%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of BRKR. FMR LLC lifted its holdings in Bruker by 21.4% during the 3rd quarter. FMR LLC now owns 14,306,122 shares of the medical research company's stock worth $987,981,000 after buying an additional 2,521,904 shares in the last quarter. London Co. of Virginia lifted its holdings in Bruker by 78.4% during the 4th quarter. London Co. of Virginia now owns 4,193,454 shares of the medical research company's stock worth $245,820,000 after buying an additional 1,843,294 shares in the last quarter. Sculptor Capital LP lifted its stake in shares of Bruker by 484.1% in the 4th quarter. Sculptor Capital LP now owns 1,714,015 shares of the medical research company's stock valued at $100,476,000 after purchasing an additional 1,420,569 shares during the period. FIL Ltd lifted its stake in shares of Bruker by 262.3% in the 4th quarter. FIL Ltd now owns 1,961,416 shares of the medical research company's stock valued at $114,978,000 after purchasing an additional 1,420,102 shares during the period. Finally, Steadfast Capital Management LP acquired a new position in shares of Bruker in the 4th quarter valued at $63,997,000. Institutional investors and hedge funds own 79.52% of the company's stock.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.